Cargando…
The fecal, oral, and skin microbiota of children with Chagas disease treated with benznidazole
BACKGROUND: Chagas disease is still prevalent in rural areas of South America. In endemic areas of Bolivia, school children are screened for the program of Chagas disease eradication of the Ministry of Health, and positive children are treated. Here, we compared the fecal, oral and skin microbiomes...
Autores principales: | Robello, Carlos, Maldonado, Doris Patricia, Hevia, Anna, Hoashi, Marina, Frattaroli, Paola, Montacutti, Valentina, Heguy, Adriana, Dolgalev, Igor, Mojica, Maricruz, Iraola, Gregorio, Dominguez-Bello, Maria G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391005/ https://www.ncbi.nlm.nih.gov/pubmed/30807605 http://dx.doi.org/10.1371/journal.pone.0212593 |
Ejemplares similares
-
Correction: The fecal, oral, and skin microbiota of children with Chagas disease treated with benznidazole
por: Robello, Carlos, et al.
Publicado: (2019) -
Hepatic changes by benznidazole in a specific treatment for Chagas disease
por: Pavan, Tycha Bianca Sabaini, et al.
Publicado: (2018) -
Access to benznidazole for Chagas disease in the United States—Cautious optimism?
por: Alpern, Jonathan D., et al.
Publicado: (2017) -
Tolerance to nifurtimox and benznidazole in adult patients with chronic Chagas’ disease
por: Jackson, Yves, et al.
Publicado: (2020) -
Solid Nanomedicines of Nifurtimox and Benznidazole for the Oral Treatment of Chagas Disease
por: Rolon, Miriam, et al.
Publicado: (2022)